<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">Based on the Chinese perspective of “centralizing COVID-19 patients and centralized inpatient treatment”, the purpose of the paper is to establish an integrated strategy for pharmaceutical care services, which focus on COVID-19 hospitalized patients and hospital pharmacists. Finally, it aims to provide guidance for hospital pharmacists to participate in the multidisciplinary team to improve COVID-19 patients’ outcome and reduce mortality, and to facilitate the pandemic control.</p>
